about
Gonadotrophins: The future.Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.Estimating xenobiotic half-lives in humans from rat data: influence of log P.Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats.Interspecies scaling of therapeutic monoclonal antibodies: initial look.The application of allometric scaling principles to predict pharmacokinetic parameters across species.Functional foods as potential therapeutic options for metabolic syndrome.Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans.Effect of essential oil from Citrus aurantium in maternal reproductive outcome and fetal anomaly frequency in rats.Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor.Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.Persistent impairment of testicular histology and sperm motility in adult rats treated with Cisplatin at peri-puberty.Role of melatonin in mitigating chemotherapy-induced testicular dysfunction in Wistar rats.
P2860
Q34975528-BB401BC2-1206-47D0-AC01-5695EA8A9E75Q35066543-31E106B3-16A2-465A-9BB1-8BC02085DC1CQ36891261-4F51E7FE-64C8-4E37-AC44-A7ADCF575A0CQ36993965-4BCA3CC1-F7FB-41B5-8043-4033216241C7Q37616947-3E626216-D405-4E86-A646-59A3950310B3Q38225274-249D55D4-D14B-4ED4-954A-2D1231AE95DEQ38582214-CB7613E0-F5A0-4BE4-8BD4-F95BA5E81B88Q38771635-AF3A969C-7AF3-4254-B036-EB23CC425F0BQ41164772-C5ECD0AA-777E-4B83-9017-B35ADFD00EEAQ42921986-9F871A3C-C7A0-41CD-9189-BC2B91898AC0Q43041164-53F9ED72-B8E8-4173-A445-11F182A05962Q45419802-A30D1BA7-020C-44BA-9167-84D112CCB72AQ46595813-DFCAA33E-7661-47F0-9D9A-F7EA10598DE5Q53261066-FA0CECE0-8D0C-451A-A991-BE9CEB070093Q53468888-BD8EA20F-A902-483F-8128-9BFE65C826E9
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Scaling basic toxicokinetic parameters from rat to man.
@ast
Scaling basic toxicokinetic parameters from rat to man.
@en
Scaling basic toxicokinetic parameters from rat to man.
@nl
type
label
Scaling basic toxicokinetic parameters from rat to man.
@ast
Scaling basic toxicokinetic parameters from rat to man.
@en
Scaling basic toxicokinetic parameters from rat to man.
@nl
prefLabel
Scaling basic toxicokinetic parameters from rat to man.
@ast
Scaling basic toxicokinetic parameters from rat to man.
@en
Scaling basic toxicokinetic parameters from rat to man.
@nl
P2093
P2860
P356
P1476
Scaling basic toxicokinetic parameters from rat to man.
@en
P2093
P2860
P304
P356
10.1289/EHP.96104400
P577
1996-04-01T00:00:00Z